FDA Closes Gap In Postmarketing Dialog With Physicians Through Online Site
Executive Summary
FDA's "evaluation agreement" between its device center and an online forum for health care practitioners is a sign of the agency's growing efforts to reach out to the physician community and improve adverse event reporting
You may also be interested in...
Social Networking Sites: Small Step For Firms, Giant Leap For Research
As social networking Web sites court big pharma with new services, firms now must decide whether such forums can play a useful role in collecting data and monitoring markets
Social Networking Sites: Small Step For Firms, Giant Leap For Research
As social networking Web sites court big pharma with new services, firms now must decide whether such forums can play a useful role in collecting data and monitoring markets
Rx Safety Is The Hub For Social Networking Site iGuard; Registries Will Fund It
The public launch of the online patient forum iGuard on April 28 emphasizes the promise that social networking sites have to help companies and regulators learn about real-world use of drugs, but also underscores the uncertainties that surround the new medium